PHASE-II TRIAL OF ELLIPTINIUM IN ADVANCED RENAL-CELL CARCINOMA

被引：0

作者：

CAILLE, P

MONDESIR, JM

DROZ, JP

KERBRAT, P

GOODMAN, A

DUCRET, JP

THEODORE, C

SPIELMAN, M

ROUESSE, J

AMIEL, JL

机构：

[1] IVES LABS INC,685 3RD AVE,NEW YORK,NY 10017

[2] SANOFI RECH,PARIS,FRANCE

[3] CTR EUGENE MARQUIS,DEPT MED,RENNES,FRANCE

来源：

CANCER TREATMENT REPORTS | 1985年 / 69卷 / 7-8期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：901 / 902

页数：2

相关论文

共 8 条

[1]

AMIEL JL, 1981, NOUV PRESSE MED, V10, P1504

[2] DRUG DEPENDENT RED-CELL ANTIBODIES AND INTRAVASCULAR HEMOLYSIS OCCURRING IN PATIENTS TREATED WITH 9 HYDROXY-METHYL-ELLIPTICINIUM [J].

CRIEL, AM ;

HIDAJAT, M ;

CLARYSSE, A ;

VERWILGHEN, RL .

BRITISH JOURNAL OF HAEMATOLOGY, 1980, 46 (04) :549-556

[3]

JURET P, 1982, CANCER TREAT REP, V66, P1909

[4]

MONDESIR JM, 1983, P ASCO, V2, P43

[5]

PAOLETTI C, 1979, CHEM BIOL INTERACT, V25, P455

[6]

PAOLETTI C, 1978, CURRENT CHEM THER, V14, P1195

[7]

YAGODA A, 1982, RECENT ADV UROLOGIC, P211

[8]

1979, WHO OFFSET PUBLICATI, V48